Jubilant Pharmova Share Price
Start SIP in Jubilant Pharmova
Start SIPJubilant Pharmova Performance
Day Range
- Low 933
- High 1,048
52 Week Range
- Low 319
- High 1,048
- Open Price958
- Previous Close952
- Volume4668324
Jubilant Pharmova Investment Rating
-
Master Rating:
-
Jubilant Pharmova has an operating revenue of Rs. 6,847.70 Cr. on a trailing 12-month basis. An annual revenue growth of 7% is good, Pre-tax margin of 2% needs improvement, ROE of 1% is fair but needs improvement. The company has a debt to equity of 58%, which is bit higher. The stock from a technical standpoint is comfortably placed above its key moving averages, around 16% and 45% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 58 which is a POOR score indicating inconsistency in earnings, a RS Rating of 83 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 51 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 163 | 202 | 170 | 186 | 204 | 189 |
| Operating Expenses Qtr Cr | 166 | 194 | 176 | 186 | 213 | 198 |
| Operating Profit Qtr Cr | 1 | 12 | -1 | 1 | 4 | 2 |
| Depreciation Qtr Cr | 13 | 13 | 12 | 12 | 11 | 11 |
| Interest Qtr Cr | 8 | 8 | 8 | 7 | 6 | 6 |
| Tax Qtr Cr | -1 | 9 | 0 | 1 | 0 | 30 |
| Net Profit Qtr Cr | -10 | 33 | -2 | 0 | 2 | -31 |
Jubilant Pharmova Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹898.15
- 50 Day
- ₹835.92
- 100 Day
- ₹768.55
- 200 Day
- ₹677.40
- 20 Day
- ₹901.53
- 50 Day
- ₹815.65
- 100 Day
- ₹759.61
- 200 Day
- ₹654.43
Jubilant Pharmova Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 969.37 |
| Second Resistance | 987.08 |
| Third Resistance | 1,004.27 |
| RSI | 72.47 |
| MFI | 79.08 |
| MACD Single Line | 36.08 |
| MACD | 34.93 |
| Support | |
|---|---|
| First Support | 934.47 |
| Second Support | 917.28 |
| Third Supoort | 899.57 |
Jubilant Pharmova Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 734,169 | 25,343,514 | 34.52 |
| Week | 375,516 | 17,191,122 | 45.78 |
| 1 Month | 428,605 | 15,986,977 | 37.3 |
| 6 Month | 546,570 | 17,052,977 | 31.2 |
Jubilant Pharmova Result Highlights
Jubilant Pharmova Synopsis
NSE-Medical-Diversified
Jubilant Pharmova is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 784.70 Cr. and Equity Capital is Rs. 15.90 Cr. for the Year ended 31/03/2024. Jubilant Pharmova Ltd. is a Public Limited Listed company incorporated on 21/06/1978 and has its registered office in the State of Uttar Pradesh, India. Company’s Corporate Identification Number(CIN) is L24116UP1978PLC004624 and registration number is 004624.| Market Cap | 15,158 |
| Sales | 734 |
| Shares in Float | 7.80 |
| No of funds | 156 |
| Yield | 0.53 |
| Book Value | 6.37 |
| U/D Vol ratio | 2.9 |
| LTDebt / Equity | 10 |
| Alpha | 0.22 |
| Beta | 1.01 |
Jubilant Pharmova Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 50.68% | 50.68% | 50.68% | 50.68% |
| Mutual Funds | 2.25% | 2.27% | 1.5% | 0.42% |
| Insurance Companies | ||||
| Foreign Portfolio Investors | 19.5% | 19.06% | 20.29% | 23.2% |
| Financial Institutions/ Banks | ||||
| Individual Investors | 17.78% | 18.72% | 18.75% | 18.24% |
| Others | 9.79% | 9.27% | 8.78% | 7.46% |
Jubilant Pharmova Management
| Name | Designation |
|---|---|
| Mr. Shyam S Bhartia | Chairman |
| Mr. Hari S Bhartia | Co-Chairman |
| Mr. Priyavrat Bhartia | Managing Director |
| Mr. Arjun Shanker Bhartia | Joint Managing Director |
| Mr. Arvind Chokhany | WholeTime Director & Group CFO |
| Dr. Ramakrishnan Arul | Whole Time Director |
| Mr. Shirish G Belapure | Independent Director |
| Mr. Sushil Kumar Roongta | Independent Director |
| Mr. Vivek Mehra | Independent Director |
| Mr. Arun Seth | Independent Director |
| Dr. Harsh Mahajan | Independent Director |
| Ms. Shivpriya Nanda | Independent Director |
Jubilant Pharmova Forecast
Price Estimates
Jubilant Pharmova Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-07-19 | Quarterly Results | |
| 2024-05-29 | Audited Results & Final Dividend | |
| 2024-02-02 | Quarterly Results | |
| 2023-10-27 | Quarterly Results | |
| 2023-07-19 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-02 | FINAL | Rs.5.00 per share(500%)Final Dividend |
| 2023-08-10 | FINAL | Rs.5.00 per share(500%)Final Dividend |
| 2022-08-12 | FINAL | Rs.5.00 per share(500%)Final Dividend |
| 2021-08-06 | FINAL | Rs.5.00 per share(500%)Final Dividend |
Jubilant Pharmova FAQs
What is Share Price of Jubilant Pharmova ?
Jubilant Pharmova share price is ₹1,041 As on 09 September, 2024 | 13:53
What is the Market Cap of Jubilant Pharmova ?
The Market Cap of Jubilant Pharmova is ₹16588.3 Cr As on 09 September, 2024 | 13:53
What is the P/E ratio of Jubilant Pharmova ?
The P/E ratio of Jubilant Pharmova is 30 As on 09 September, 2024 | 13:53
What is the PB ratio of Jubilant Pharmova ?
The PB ratio of Jubilant Pharmova is 3 As on 09 September, 2024 | 13:53